The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|4|334-341

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.4, 2015-04, pp. : 334-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Endocannabinoid System and Huntington's Disease

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 335-347

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid/Endovanilloid System and Depression

By  

Current Neuropharmacology, Vol. 12, Iss. 5, 2014-09 ,pp. : 462-474

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid System and Pain

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-01 ,pp. : 403-421

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid System in Huntington's Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 23, 2008-08 ,pp. : 2317-2325

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid System in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 23, 2008-08 ,pp. : 2337-2346

Bentham Science Publishers

Access to resources Recommend Favorite